Tilray Brands, Inc. (NASDAQ:TLRY) (TSX:TLRY) announced the launch of Tilray Medical, a global medical platform that consolidates the its medical cannabis brands under one strategy, mission, and vision, Financial Post writes.
“Tilray is the global leader in the advancement of cannabinoid-based medicine, with a focus on providing research-backed medical cannabis products to physicians, pharmacies, and patients,” Denise Faltischek, head of international and chief strategy officer, said. “By unifying the global medical divisions of Tilray and Aphria under a cohesive strategy and mission, Tilray Medical emerges as the premier global supplier of a portfolio of high-quality, effective medical cannabis brands and products for patients in need around the world.”
